Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IC TITAN: Intracoronary Eptifibatide in STEMI
NCT00719914Phase 2Terminated
- Sponsor
- Brigham and Women's Hospital
- Start
- Nov 2007
- Primary completion
- Nov 2008
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ST elevation myocardial infarction (STEMI) comparing Intracoronary Eptifibatide with Intracoronary Placebo (2 arms). Primary endpoint: Improvement in Percent Diameter Stenosis of the Culprit Artery at 30 days. Started Nov 2007; status: terminated.
02
Drugs
eptifibatide
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT00719914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00719914.